Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
China’s Shenzhen Hepalink Pharmaceutical will pay $205 million to acquire the drug actives manufacturer Cytovance Biologics. Cytovance, based in Oklahoma City, says the deal will help it implement a plan to add 5,000-L and 10,000-L mammalian cell reactors as well as 1,000-L and 5,000-L microbial fermentors. Hepalink says the deal aims to boost its international presence. The Chinese firm already owns Scientific Protein Laboratories, a Wisconsin-based heparin producer.
This article has been sent to the following recipient: